Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App





AI-Based Breathalyzer Can Electronically `Smell` Coronavirus and Detect Infection in Under Two Minutes

By LabMedica International staff writers
Posted on 07 Jan 2021
A simple breathalyser test uses artificial intelligence (AI) to electronically "smell' the novel coronavirus and detect infection in less than two minutes.

Scientists at the Gadjah Mada University (Jogjakarta, Indonesia) have developed the GeNose C19 or Gadjah Mada Electronic Nose that rapidly detects COVID-19 using only a person’s breath. More...
The electronic-based diagnostic tool uses the cloud computing system to deliver real-time diagnosis results and can also be run in parallel through a centralized diagnostic process to maintain data validity for all connected devices.

The device uses powerful filters and suction to remove all COVID-19 droplets or particles and sterilize itself for the next test. GeNose C19 offers the advantages of lower cost per test, instant test results, ease of mass production, and high specificity and sensitivity. The Indonesian government has granted a distribution permit for GeNose C19 which is already being used to screen patients for COVID-19 by three hospitals across the country.

"We need faster screening to prevent people getting infected," said Bambang Brodjonegoro, Indonesia's Minister for Research and Technology. "This will accelerate the detection process and mitigate the risk of the pandemic spreading."

Related Links:
Gadjah Mada University


Gold Member
Universal Transport Solution
Puritan®UniTranz-RT
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Homocysteine Quality Control
Liquichek Homocysteine Control
Automated MALDI-TOF MS System
EXS 3000
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.